CEL SCI (CVM) CEO Geert Kersten purchases 100,000 restricted shares

Rhea-AI Filing Summary

CEL SCI CORP director and Chief Executive Officer Geert R. Kersten reported buying additional company shares. On May 13, 2026, he purchased 100,000 shares of restricted common stock directly from the company at $1.19 per share, equal to the May 12, 2026 closing price. Following this transaction, his direct holdings increased to 222,497 common shares, indicating a substantial expansion of his personal equity stake.

Insider Trade Summary

Net Buyer: 100,000 shares ($119,000)

Net Buy 1 txn

Insider KERSTEN GEERT R

Role Chief Executive Officer

Bought 100,000 shs ($119K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	100,000	$1.19	$119K

Holdings After Transaction: Common Stock — 222,497 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Shares purchased: 100,000 shares Purchase price: $1.19 per share Total holdings after: 222,497 shares

3 metrics

Shares purchased 100,000 shares Restricted common stock bought on May 13, 2026

Purchase price $1.19 per share Matched May 12, 2026 closing price

Total holdings after 222,497 shares Direct common stock ownership after transaction

Key Terms

restricted stock, closing price, open-market purchase

3 terms

restricted stock financial

"purchased 100,000 shares of restricted stock directly from the Company"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

closing price financial

"at the closing price on May 12, 2026, the most recent closing price available"

open-market purchase financial

"transaction_action": "open-market purchase""

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KERSTEN GEERT R

(Last) (First) (Middle)

8229 BOONE BLVD

STE 802

(Street)

VIENNA VIRGINIA 22182

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CEL SCI CORP [ CVM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/13/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/13/2026		P		100,000(1)	A	$1.19	222,497	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On May 13, 2026, Mr. Kersten purchased 100,000 shares of restricted stock directly from the Company at the closing price on May 12, 2026, the most recent closing price available.

	Geert Kersten	05/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did CEL SCI CORP (CVM) report for Geert Kersten?

CEL SCI CORP reported that CEO and director Geert R. Kersten purchased 100,000 shares of restricted common stock. The shares were acquired directly from the company at the May 12, 2026 closing price, increasing his direct ownership stake significantly.

How many CEL SCI CORP (CVM) shares did the CEO buy and at what price?

Geert R. Kersten bought 100,000 CEL SCI CORP common shares at $1.19 per share. The footnote states this price matched the May 12, 2026 closing price, and the shares were issued as restricted stock directly by the company.

Is the CEL SCI CORP (CVM) CEO’s recent share purchase an open-market trade?

The Form 4 classifies the transaction as a purchase, but the footnote clarifies it was 100,000 shares of restricted stock bought directly from CEL SCI CORP at the most recent closing price, rather than a typical open-market exchange trade.

What is Geert Kersten’s CEL SCI CORP (CVM) share ownership after this transaction?

After the reported purchase, Geert R. Kersten directly owns 222,497 CEL SCI CORP common shares. This reflects the addition of 100,000 newly purchased restricted shares to his prior holdings as shown in the Form 4 filing totals.

Were the CEL SCI CORP (CVM) shares purchased by the CEO restricted?

Yes. The Form 4 footnote states that on May 13, 2026, Geert R. Kersten purchased 100,000 shares of restricted stock directly from CEL SCI CORP at the May 12, 2026 closing price, indicating transfer limitations typically associated with restricted shares.